Skip to main content

Gilead Sciences, Inc.'s Form 4 filing

Assembly Biosciences, Inc. (ASMB) · filed Oct 3, 2025

Accession no.
0001123292-25-000510
Filed
Oct 3, 2025
Trade date
Aug 8, 2025
Filing delay
56 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction and 2 derivative transactions. It was filed 56 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Gilead Sciences, Inc.CIK 000088209510% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 8, 2025Common StockPPurchaseAcquired+2,295,920–F1–4,505,391Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 8, 2025Common StockPPurchaseAcquired+1,147,960–F1–1,147,960Direct
Aug 8, 2025Common StockPPurchaseAcquired+1,147,960–F1–1,147,960Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Pursuant to a securities purchase agreement between the Issuer and the Reporting Person, the Issuer issued and sold to the Reporting Person in a private placement 2,295,920 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), Class A warrants to purchase 1,147,960 shares of Common Stock (the "Class A Warrants"), and Class B warrants to purchase 1,147,960 shares of Common Stock (the "Class B Warrants"), at a combined price of $19.60 per share of Common Stock and accompanying one half of one Class A Warrant and one half of one Class B Warrant.

Referenced by the price of 1 transaction in Table I and 2 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)